Same-visit hepatitis C testing and treatment to accelerate cure among people who inject drugs (the QuickStart Study): a cluster randomised cross-over trial protocol
Introduction Despite universal access to government-funded direct-acting antivirals (DAAs) in 2016, the rate of hepatitis C treatment uptake in Australia has declined substantially. Most hepatitis C is related to injecting drug use; reducing the hepatitis C burden among people who inject drugs (PWID...
Saved in:
| Main Authors: | Andrew B Forbes, Jessica Kasza, Thomas L Snelling, David Anderson, Joseph S Doyle, Peter Higgs, Margaret E Hellard, Nick Scott, Alisa E Pedrana, Alexander J Thompson, Jessica Howell, Timothy Spelman, Beatriz Camesella, Imogen Elsum, Kico Chan, Mark A Stoové, Paul M Dietze, Mellissa Bryant, Katherine Heath, Rodney Guzman, Caitlin Douglass, Amanda Wade, Kate Allardice, Sally Von Bibra, Jacqui Richmond, Nada Andric, Rachel Sacks‐Davis |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2024-07-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/14/7/e083502.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Practical solutions to resolve social barriers to hepatitis C treatment initiation among people who inject drugs: a qualitative study
by: Phyo Aung, et al.
Published: (2024-12-01) -
Inference for the treatment effect in staircase designs with continuous outcomes: a simulation study
by: Ehsan Rezaei-Darzi, et al.
Published: (2025-05-01) -
A longitudinal study of alcohol consumption among adults in Victoria, Australia during the COVID-19 pandemic.
by: Tianhui Ke, et al.
Published: (2024-01-01) -
Modelling the impact of migrants on the success of the HIV care and treatment program in Botswana.
by: Tafireyi Marukutira, et al.
Published: (2020-01-01) -
Hepatitis C virus notification rates in Australia are highest in socioeconomically disadvantaged areas.
by: Samuel W Hainsworth, et al.
Published: (2018-01-01)